Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add more filters










Publication year range
1.
Rocz Akad Med Bialymst ; 41(2): 374-80, 1996.
Article in English | MEDLINE | ID: mdl-9020549

ABSTRACT

The study was carried out on 20 newborns with diagnosed premature ablation of placenta of 0,I,II clinical degree. In comparison to healthy newborns (n = 30) statistically significant differences were proved in: ATIII activity-48% (65%), plasminogen concentration-50% (63%), alpha 2antyplasmin activity 53% (67%); euglobulin clot fibrinolysis time 70 (95) min., and fibrinogen concentration 1.4 (1.8) g/l. The presented differences prove increased coagulation system activation in newborns from mothers with symptoms of premature ablation of placenta. Activity changes of hemostasis system in cases of premature ablation of placenta have the features of disorders accompanying intrauterine fetal anoxia.


Subject(s)
Abruptio Placentae/blood , Asphyxia Neonatorum/diagnosis , Fetal Blood/physiology , Hemostasis/physiology , Acid-Base Equilibrium , Apgar Score , Asphyxia Neonatorum/blood , Asphyxia Neonatorum/etiology , Female , Fibrinogen/analysis , Humans , Infant, Newborn , Pregnancy
2.
Article in English | MEDLINE | ID: mdl-1695173

ABSTRACT

Some haemostatic parameters (AT III, alpha 2-AP, C1-INH, kallikrein, F.XII, fibrinogen, plasminogen, euglobulin lysis time, FDP and ethanol test) were studied in patients with deep (DVT) and superficial (SVT) venous thrombosis. The patients with DVT revealed significantly decreased AT III activity, increased alpha 2-AP, C1-INH activity, fibrinogen and FDP concentrations and prolongation of euglobulin lysis time. Ethanol gelation test was positive in 61% in DVT group. Plasminogen level was unchanged in patients with DVT. No significant changes in these parameters were found in SVT group. Only the ethanol gelation test was positive in 21% in this group. These results show a markedly expressed phenomenon of hypercoagulability in the group of patients with DVT and suggest that in the treatment different therapeutic procedures should be considered which influence these specific changes in these coagulation parameters.


Subject(s)
Thrombophlebitis/physiopathology , Antithrombin III/metabolism , Complement C1 Inactivator Proteins/metabolism , Factor XII/metabolism , Fibrinolysin/metabolism , Fibrinolysis , Hemostasis , Humans , Prekallikrein/metabolism , alpha-Macroglobulins/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...